|
HS Code |
467698 |
| Product Name | 2-Chloro-3-Fluorobenzyl Bromide |
| Cas Number | 57381-68-9 |
| Molecular Formula | C7H5BrClF |
| Molecular Weight | 223.47 g/mol |
| Appearance | Colorless to pale yellow liquid |
| Boiling Point | 96-99°C at 0.4 mmHg |
| Density | 1.62 g/cm³ |
| Purity | Typically ≥ 97% |
| Refractive Index | n20/D 1.573 |
| Solubility | Insoluble in water, soluble in most organic solvents |
| Smiles | C1=CC(=C(C(=C1)Cl)F)CBr |
| Inchi | InChI=1S/C7H5BrClF/c8-4-5-2-1-3-6(9)7(5)10/h1-3H,4H2 |
| Synonyms | α-Bromo-2-chloro-3-fluorotoluene |
| Storage Temperature | Store at 2-8°C |
As an accredited 2-Chloro-3-Fluorobenzyl Bromide factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 2-Chloro-3-Fluorobenzyl Bromide prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
2-Chloro-3-Fluorobenzyl Bromide has built a reputation in chemical research circles for its reliable reactivity and clear impact in synthesis tasks. The compound features a distinct chloro and fluoro substitution on a benzyl ring, paired with a bromide leaving group. Its chemical model – C7H5BrClF – means it packs versatility and functional reactivity in a fairly compact molecule, and the bromide position often attracts attention in nucleophilic substitution reactions. In hands-on work, I’ve found it remains manageable under standard lab temperatures and holds steady during common purification steps. Labs value this resilience, as not every compound in similar families behaves with the same predictable manner.
It’s impossible to talk about this compound without touching on its most frequent uses. Researchers gravitate toward it, not for ornamental reasons, but because the molecule plays a key part in the synthesis of more complex aromatic compounds. Medicinal chemistry teams often start with intermediates like 2-Chloro-3-Fluorobenzyl Bromide when crafting targeted molecules, especially those aimed at central nervous system pathways or particular receptor sites. In small-scale studies, I've seen it used as a backbone for kinase inhibitor candidates or when exploring substitutions on heterocyclic scaffolds. The presence of both chloro and fluoro groups gives medicinal chemists an edge — small changes in electronegativity or steric bulk can turn a mediocre lead into a promising one.
The fine-tuning available with 2-Chloro-3-Fluorobenzyl Bromide comes straight from its dual halogen substitutions. Plenty of benzyl bromides exist, but not every one can offer the same fine gradation of reactivity or outcome stability during substitution. If you take a basic benzyl bromide and try to synthesize fluorinated analogues, you’ll often run into complications — competing side reactions, lower yields, and unwelcome by-products. In contrast, with 2-Chloro-3-Fluorobenzyl Bromide, the chlorine and fluorine are already in place, saving time and leaving less room for error.
From a synthetic standpoint, this halogen pattern doesn’t just sound impressive. The electron-withdrawing effects aren’t minor. They can shift reactivity, adjust pKa values, and in biochemistry experiments, sometimes increase binding selectivity, especially if the target molecule recognizes subtle changes around the benzyl position. During my own time handling a few dozen reductive amination reactions, analogues with this particular substitution held up better when transitioned to scale-up, with fewer by-product headaches at each step.
Most labs prefer material in the 98%+ purity range. Open containers within a fume hood, as the volatility and odor call for respect. I’ve learned not to underestimate the importance of controlling light and air exposure; although it generally maintains form, any benzyl bromide risks minor decomposition under rough treatment or prolonged storage. A tightly sealed amber bottle, tucked away from excess heat, stretches shelf life without much fuss. During synthesis runs in glass reactors, the consistency of this compound has meant tighter yields and lower waste, easing the burden on downstream purification.
Its solid state (often a pale crystalline powder or fine granules) means it measures out cleanly without raising the static issues some liquid reagents present. This straightforward handling may seem minor, but it translates into smoother day-to-day operations, fewer safety complaints, and a much lower risk of cross-contamination between projects. The melting point typically falls in a handleable range, which reduces thermal management headaches compared to other substituted benzyl halides.
Synthetic chemists look for leverage at every stage. The challenge isn’t just to assemble a molecule but to design a set of building blocks that save time, cut down on toxic by-products, and keep downstream modifications viable. In that respect, 2-Chloro-3-Fluorobenzyl Bromide serves as both a shortcut and a stabilizer. The carefully placed halogens control reactivity, often helping teams steer reactions with greater selectivity and fewer surprises.
During collaborations with pharmaceutical scientists, I’ve observed that this sort of intermediate allows for rapid analog development. If you’re chasing a new kinase pathway, tweaking the benzyl ring with precision halogens can mean the difference between a promising candidate and another dead end. There’s a reason global pharma companies track their stocks of these intermediates closely. A robust, well-understood supply chain for this compound can help avoid project holdups and keep medicinal chemistry screens on pace.
One of the strengths of 2-Chloro-3-Fluorobenzyl Bromide is the improved selectivity in further transformations, such as nucleophilic substitutions. A plain benzyl bromide carries reactive energy, but it often proves unruly in the presence of strong nucleophiles or under basic conditions. Substituted versions like the para-chloro or meta-fluoro analogues provide some control, but without the combination found here, users must often choose between higher selectivity and reduced yield. The unique electronegative pair in the 2- and 3- positions reduces electron density on the ring, nudging reactivity into a more predictable, manageable range.
Other benzyl bromides sometimes lure research teams with a lower price or widespread commercial availability. Saving on procurement, though, often comes back to haunt labs once they run into batch variability, purity drops, or extra purification work. My colleagues and I traded stories of how skipping the right intermediate, only to spend weeks struggling with clean-up or unexpected side products, can delay entire projects. In comparison, the upfront investment in a well-characterized compound like 2-Chloro-3-Fluorobenzyl Bromide streamlines these headaches and aligns with green chemistry principles by reducing waste.
Long-term studies in medicinal chemistry labs have tracked how this compound cuts down the time for SAR (structure-activity relationship) sweeps. Instead of multiple synthetic steps for dual halogenation, a single intermediate fast-tracks the process. In one notable project focused on central nervous system receptor ligands, starting from 2-Chloro-3-Fluorobenzyl Bromide meant the team could build out a full suite of analogues in under two weeks. In similar setups using standard benzyl bromide or single-halogen variants, the calendar stretched by another month, mostly due to repeat work and tricky purifications.
I’ve found it rewarding to see these small decisions bear out downstream, especially in pilot plant runs. Scale-up teams work under tight timeframes, so cutting out unnecessary steps makes lives easier. Handling a trustworthy intermediate means fewer surprises — lab-scale procedures translate smoothly to the plant, and batch reproducibility stays high. Pharmaceutical firms keep a close eye on supply reliability and storage stability, both areas where this compound outshines more basic analogues.
In the modern lab, attention to chemical stewardship has grown. While 2-Chloro-3-Fluorobenzyl Bromide performs admirably in terms of synthetic goals, it also presents manageable safety considerations. Proper use of gloves, goggles, and effective fume extraction minimizes risk. Some may recall days gone by when outdated safety protocols led to regular issues, but shifts in laboratory culture (reinforced by precise intermediates like this one) mean healthier workplaces and fewer incidents.
Waste minimization remains a real topic. By choosing intermediates that support higher overall yields and reduce side-product formation, teams make meaningful progress toward lower environmental impact. My own experience in green chemistry programs underscores how switching to a more reactive but controlled intermediate eliminates persistent organic pollutants from waste streams. While disposal of halogenated organics still requires conscious management, the minimization of volume and the reduction in failed reaction attempts matters on both lab and industrial scales.
In my years navigating chemical procurement, I’ve witnessed supply chain interruptions derail otherwise promising projects. Bottlenecked intermediates force research to slow or, worse, pause. 2-Chloro-3-Fluorobenzyl Bromide benefits from its established role and relatively stable manufacturing routes. Trusted suppliers have built up reliable production capabilities, and the consistency of post-synthesis handling — large-scale recrystallization, bulk packaging, routine purity checks — gives end users confidence. Routine QA/QC measures, including detailed NMR and mass spectrometry profiles, support both research- and production-scale needs.
This shouldn’t be taken for granted. Several analogues see more frequent variation batch-to-batch, making planning difficult for scale-up campaigns. In firms where reproducibility and clear documentation lead directly to regulatory approval timelines, dependable starting materials anchor the whole process. During years of project management, I saw time and again that consistent intermediates reduce delays, keep analytical queries at bay, and help avoid costly regulatory retesting.
Innovation in chemical research doesn’t always mean revolutionary new reactions; often, it arrives in the form of more refined building blocks. The use of dual halogen-substituted benzyl bromides continues to expand, especially as drug developers seek nuanced SAR profiles and greater physicochemical diversity. High-throughput screening facilities increasingly rely on well-characterized intermediates like 2-Chloro-3-Fluorobenzyl Bromide to rapidly explore structural space.
Imagine a world where AI-driven drug design leverages reliable, data-rich intermediates. The foundations for such a future lie in solid, reproducible building blocks. Drawing on experiences supporting computational chemists, the rising number of digital screening programs makes use of libraries built on chemically diverse cores such as this one. The capacity to link virtual hit identification directly with accessible chemical building blocks streamlines the journey from idea to physical molecule, and this compound is already part of that movement.
Labs constantly battle unplanned delays — shipment slowdowns, rapid consumption during hit-to-lead campaigns, or the need to pivot quickly based on new data. The stability and ready availability of 2-Chloro-3-Fluorobenzyl Bromide help mitigate those issues. Sourcing the material in standard lab-scale quantities (5 g, 10 g, or more) supports day-to-day research, while bulk orders accommodate scale-up or pilot-plant initiatives. In emergency cases, reliable distributors can fulfill rush orders, drawing upon established stockpiles.
Another underappreciated solution lies in the consistent documentation and analytical data made available by reputable suppliers. Full NMR, HPLC, and mass spectrometry reports mean users confirm identity and purity with confidence, integrating data seamlessly into their project management workflows. My own record-keeping grew remarkably easier once our lab standardized on well-analyzed building blocks — audit trails improved, experiments ran smoother, and stress levels dropped on both the technical and compliance fronts.
The research landscape expects more than just functional chemicals; attention to quality and ethical sourcing weighs heavily in procurement decisions. With regulations growing stricter and audits more common, suppliers and users alike pay closer attention to certifications, traceability, and responsible manufacturing practices. During my work with cross-functional compliance teams, I discovered that organizations integrating these expectations into their supply chain seldom ran afoul of regulatory agencies and enjoyed more predictable project outcomes.
2-Chloro-3-Fluorobenzyl Bromide stands as an example of how robust processes and quality-driven approaches reduce the risk of contamination, ensure delivering consistent results across research groups, and build long-term trust between suppliers and end users. This transparency shortens the learning curve for new staff and sets a higher standard for collaborative projects across global sites.
Modern science doesn’t stand still. Advances in molecular diagnostics, bioconjugation, and even polymer chemistry call for ever more sophisticated building blocks. Research into advanced functional materials often employs molecules with unique halogenation, and 2-Chloro-3-Fluorobenzyl Bromide meets this need for specificity. During recent collaborations with biotech startups, I witnessed how their transition from concept to minimum viable product drew heavily on robust, well-understood intermediates, including this one.
The quality and reactivity profile of this compound gives innovators the head start needed to bring fresh ideas to market. A startup tackling a new imaging agent for in vivo diagnostics can’t wait for lengthy re-optimization of starting materials: the clock (and the funding) tick quickly. Ready access to a proven intermediate tightens timelines and supports the broader ecosystem of new entrants to the chemical, pharmaceutical, and materials science sectors.
Training the next generation of chemists involves exposing students and trainees to practical, reliable reagents. My years as a teaching assistant and laboratory instructor taught me the value of using intermediates that behave predictably and reflect larger industry standards. 2-Chloro-3-Fluorobenzyl Bromide regularly features in educational lab settings, often in upper-level undergraduate and graduate experiments, giving learners firsthand experience with halogenated aromatic chemistry. This real-world exposure shortens the transition from academic to industrial research roles.
Course curricula increasingly merge theory and application. By using even a single molecule like this one, educators reinforce lessons about structure-reactivity relationships, functional group interconversions, and the logic behind substitution patterns. The halosubstitution positions (chloro and fluoro) fit naturally into discussions of electronic effects and mechanism-based design, while the bromide leaving group provides tangible experience for alkylation and cross-coupling strategies.
The story of 2-Chloro-3-Fluorobenzyl Bromide is built on more than chemical structure. Its popularity among researchers, educators, and process chemists comes from tangible, real-earned rewards. Over the span of my career, ongoing improvements in supply, purity, safety documentation, and application breadth have helped embed this compound in a broad range of projects. Whether supporting medicinal chemistry discovery, easing compliance headaches, or improving laboratory training, the role of this intermediate grows each year as fields evolve and demand sharper, faster, more reliable results.